Louisa S. Chard

2.0k total citations
39 papers, 1.5k citations indexed

About

Louisa S. Chard is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Louisa S. Chard has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Louisa S. Chard's work include Virus-based gene therapy research (20 papers), CAR-T cell therapy research (16 papers) and Cancer Research and Treatments (11 papers). Louisa S. Chard is often cited by papers focused on Virus-based gene therapy research (20 papers), CAR-T cell therapy research (16 papers) and Cancer Research and Treatments (11 papers). Louisa S. Chard collaborates with scholars based in United Kingdom, China and United States. Louisa S. Chard's co-authors include Yaohe Wang, Graham J. Belsham, Nicholas R. Lemoine, Junichi Tanaka, Jerry Pelletier, Zhenguo Cheng, Yoshihiro Kaku, Tatsuo Higa, Lisa Lindqvist and Monika Oberer and has published in prestigious journals such as Nature Communications, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Louisa S. Chard

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louisa S. Chard United Kingdom 21 714 532 508 274 258 39 1.5k
Neeraja Idamakanti United States 23 925 1.3× 1.2k 2.3× 441 0.9× 208 0.8× 97 0.4× 38 1.7k
Jieyuan Jiang China 21 767 1.1× 155 0.3× 712 1.4× 93 0.3× 134 0.5× 39 1.5k
Fernando Esquivel‐Guadarrama Mexico 21 509 0.7× 220 0.4× 416 0.8× 153 0.6× 1.1k 4.4× 49 1.8k
Carolina S. Ilkow Canada 17 509 0.7× 660 1.2× 585 1.2× 29 0.1× 298 1.2× 41 1.2k
George E. Mark United States 22 861 1.2× 177 0.3× 208 0.4× 154 0.6× 262 1.0× 54 1.5k
Konstantin Doronin United States 26 1.2k 1.7× 1.5k 2.9× 741 1.5× 64 0.2× 221 0.9× 40 1.9k
Eric Bartee United States 22 774 1.1× 623 1.2× 616 1.2× 38 0.1× 785 3.0× 49 2.0k
Ellen M. Westerhout Netherlands 17 1.4k 1.9× 313 0.6× 213 0.4× 120 0.4× 294 1.1× 23 1.9k
Beihua Dong United States 24 1.6k 2.2× 322 0.6× 359 0.7× 363 1.3× 1.4k 5.3× 43 2.9k
Kevin A. Cassady United States 23 557 0.8× 887 1.7× 695 1.4× 52 0.2× 408 1.6× 59 1.6k

Countries citing papers authored by Louisa S. Chard

Since Specialization
Citations

This map shows the geographic impact of Louisa S. Chard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louisa S. Chard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louisa S. Chard more than expected).

Fields of papers citing papers by Louisa S. Chard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louisa S. Chard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louisa S. Chard. The network helps show where Louisa S. Chard may publish in the future.

Co-authorship network of co-authors of Louisa S. Chard

This figure shows the co-authorship network connecting the top 25 collaborators of Louisa S. Chard. A scholar is included among the top collaborators of Louisa S. Chard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louisa S. Chard. Louisa S. Chard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Rui, Lihong Wang, Zhe Zhang, et al.. (2025). Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer. Journal for ImmunoTherapy of Cancer. 13(5). e010341–e010341. 2 indexed citations
2.
Ning, Weihai, H. J. Yang, Louisa S. Chard, et al.. (2025). The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials. Nature Communications. 16(1). 6934–6934. 1 indexed citations
3.
Wang, Lihong, Yangyang Wu, Jingjing Wang, et al.. (2023). A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma. Cancer Letters. 568. 216303–216303. 7 indexed citations
4.
Wang, Yanru, Yanru Wang, Louisa S. Chard, et al.. (2023). Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy. Frontiers in Immunology. 14. 1126969–1126969. 12 indexed citations
5.
Baleeiro, Renato B., Peng Liu, Louisa S. Chard, et al.. (2023). Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 11(8). e007336–e007336. 13 indexed citations
6.
Song, Qianqian, Junqi Li, Louisa S. Chard, et al.. (2022). Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene. Molecular Therapy — Oncolytics. 25. 264–275. 8 indexed citations
7.
Baleeiro, Renato B., Peng Liu, Louisa S. Chard, et al.. (2022). MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. OncoImmunology. 11(1). 2080329–2080329. 21 indexed citations
8.
Zhao, Yuanyuan, Louisa S. Chard, Zhenguo Cheng, Yaohe Wang, & Lingling Si. (2022). Natural products targeting glycolysis in cancer. Frontiers in Pharmacology. 13. 1036502–1036502. 20 indexed citations
9.
Wang, Zhizhong, Zhenguo Cheng, Shuangshuang Lu, et al.. (2022). Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma. Frontiers in Immunology. 13. 896627–896627. 7 indexed citations
10.
Wang, Jingjing, Danhua Zhang, Lijie Song, et al.. (2022). The two-faced role of ATF2 on cisplatin response in gastric cancer depends on p53 context. Cell & Bioscience. 12(1). 77–77. 2 indexed citations
11.
Marelli, Giulia, Louisa S. Chard, Ming Yuan, et al.. (2021). A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer. Journal for ImmunoTherapy of Cancer. 9(1). e001624–e001624. 30 indexed citations
12.
Miao, Jinxin, Jianyao Wang, Haoze Li, et al.. (2020). Promising xenograft animal model recapitulating the features of human pancreatic cancer. World Journal of Gastroenterology. 26(32). 4802–4816. 19 indexed citations
13.
Ferguson, M. S., Louisa S. Chard, Rathi Gangeswaran, et al.. (2020). Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus. Molecular Therapy. 28(5). 1263–1275. 36 indexed citations
14.
Yuan, Ming, Pengju Wang, Louisa S. Chard, Nicholas R. Lemoine, & Yaohe Wang. (2016). A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors. Journal of Visualized Experiments. 12 indexed citations
15.
Chard, Louisa S., Nicholas R. Lemoine, & Yaohe Wang. (2015). New role of Interleukin-10 in enhancing the antitumor efficacy of oncolytic vaccinia virus for treatment of pancreatic cancer. OncoImmunology. 4(9). e1038689–e1038689. 22 indexed citations
16.
Yuan, Ming, Wensheng Zhang, Jun Wang, et al.. (2015). Efficiently Editing the Vaccinia Virus Genome by Using the CRISPR-Cas9 System. Journal of Virology. 89(9). 5176–5179. 89 indexed citations
17.
Yuan, Ming, Xuefei Gao, Louisa S. Chard, et al.. (2015). A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9. Molecular Therapy — Methods & Clinical Development. 2. 15035–15035. 47 indexed citations
18.
Chard, Louisa S., Eleni Maniati, Pengju Wang, et al.. (2014). A Vaccinia Virus Armed with Interleukin-10 Is a Promising Therapeutic Agent for Treatment of Murine Pancreatic Cancer. Clinical Cancer Research. 21(2). 405–416. 60 indexed citations
19.
Tysome, James R., Xiaozhu Li, Shengdian Wang, et al.. (2012). A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity. Clinical Cancer Research. 18(24). 6679–6689. 56 indexed citations
20.
Bailey, Dalan, Louisa S. Chard, Pradyot Dash, Tom Barrett, & Ashley C. Banyard. (2007). Reverse genetics for peste-des-petits-ruminants virus (PPRV): Promoter and protein specificities. Virus Research. 126(1-2). 250–255. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neeraja Idamakanti Breakdown of academic impact, for papers by Jieyuan Jiang Breakdown of academic impact, for papers by Fernando Esquivel‐Guadarrama Breakdown of academic impact, for papers by Carolina S. Ilkow Breakdown of academic impact, for papers by George E. Mark Breakdown of academic impact, for papers by Konstantin Doronin Breakdown of academic impact, for papers by Eric Bartee Breakdown of academic impact, for papers by Ellen M. Westerhout Breakdown of academic impact, for papers by Beihua Dong Breakdown of academic impact, for papers by Kevin A. Cassady
Rankless by CCL
2026